TALARIS THERAPEUTICS INC (TALS)
Institutional ownership reported to the SEC as of Q3 2024, across 11 quarters.
1
Reporting holders
$1.4K
Reported value
0.0%
Held as options
-45
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Lindbrook Capital, LLC | $1.4K | 56 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 1 | $1.4K | 56 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 46 | $74.0M | 26,321,499 | 4 | 13 | 16 | 0.0% |
| Q2 2023 | 54 | $75.5M | 24,834,784 | 21 | 9 | 20 | 0.0% |
| Q1 2023 | 44 | $46.6M | 24,766,987 | 8 | 15 | 10 | 0.0% |
| Q4 2022 | 40 | $23.7M | 23,270,974 | 9 | 14 | 7 | 0.0% |
| Q3 2022 | 52 | $72.2M | 27,296,238 | 11 | 15 | 10 | 0.0% |
| Q2 2022 | 57 | $130.4M | 28,886,199 | 11 | 9 | 20 | 0.0% |
| Q1 2022 | 51 | $286.9M | 29,159,055 | 6 | 13 | 13 | 0.0% |
| Q4 2021 | 51 | $456.7M | 29,870,697 | 11 | 20 | 6 | 0.0% |
| Q3 2021 | 48 | $349.4M | 25,871,191 | 5 | 16 | 10 | 0.0% |
| Q2 2021 | 50 | $379.4M | 25,977,871 | 50 | 0 | 0 | 0.0% |